Epilepsy, X-Linked, with Variable Learning Disabilities and Behavior Disorders
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
SYN1 loss-of-function mutations in autism and partial epilepsy cause impaired synaptic function.
|
21441247 |
2011 |
Epilepsy, X-Linked, with Variable Learning Disabilities and Behavior Disorders
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
Identification of a mutation in synapsin I, a synaptic vesicle protein, in a family with epilepsy.
|
14985377 |
2004 |
Epilepsy, X-Linked, with Variable Learning Disabilities and Behavior Disorders
|
0.700 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Epilepsy, X-Linked, with Variable Learning Disabilities and Behavior Disorders
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
Epilepsy, X-Linked, with Variable Learning Disabilities and Behavior Disorders
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Epilepsy, X-Linked, with Variable Learning Disabilities and Behavior Disorders
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Schizophrenia
|
0.320 |
Biomarker
|
disease |
PSYGENET |
The allelic frequencies of rs1142636 (SYN1) were associated with schizophrenia (P < 0.05), respectively.
|
22807112 |
2012 |
Schizophrenia
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
The allelic frequencies of rs1142636 (SYN1) were associated with schizophrenia (P < 0.05), respectively.
|
22807112 |
2012 |
Schizophrenia
|
0.320 |
Biomarker
|
disease |
PSYGENET |
These findings demonstrate that the nucleocytoplasmic shuttling of dysbindin-1 regulates synapsin I expression and thus may be involved in the pathogenesis of schizophrenia.
|
20921223 |
2010 |
Schizophrenia
|
0.320 |
AlteredExpression
|
disease |
BEFREE |
These findings demonstrate that the nucleocytoplasmic shuttling of dysbindin-1 regulates synapsin I expression and thus may be involved in the pathogenesis of schizophrenia.
|
20921223 |
2010 |
Mental Depression
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
Q555X-hSynI induced larger facilitation and post-tetanic potentiation in excitatory synapses and stronger depression after long trains in inhibitory synapses.
|
23406870 |
2013 |
Mental Depression
|
0.310 |
Biomarker
|
disease |
PSYGENET |
Q555X-hSynI induced larger facilitation and post-tetanic potentiation in excitatory synapses and stronger depression after long trains in inhibitory synapses.
|
23406870 |
2013 |
Depressive disorder
|
0.310 |
Biomarker
|
disease |
PSYGENET |
Q555X-hSynI induced larger facilitation and post-tetanic potentiation in excitatory synapses and stronger depression after long trains in inhibitory synapses.
|
23406870 |
2013 |
Depressive disorder
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
Q555X-hSynI induced larger facilitation and post-tetanic potentiation in excitatory synapses and stronger depression after long trains in inhibitory synapses.
|
23406870 |
2013 |
Mental Depression
|
0.310 |
Biomarker
|
disease |
PSYGENET |
Synapsin-I- and synapsin-II-null mice display an increased age-dependent cognitive impairment.
|
18713831 |
2008 |
Depressive disorder
|
0.310 |
Biomarker
|
disease |
PSYGENET |
Synapsin-I- and synapsin-II-null mice display an increased age-dependent cognitive impairment.
|
18713831 |
2008 |
Mental Depression
|
0.310 |
Biomarker
|
disease |
PSYGENET |
Simultaneously, the region-dependent alteration of synapsin I is correlated with depression-associated behaviors.
|
17392736 |
2007 |
Depressive disorder
|
0.310 |
Biomarker
|
disease |
PSYGENET |
Simultaneously, the region-dependent alteration of synapsin I is correlated with depression-associated behaviors.
|
17392736 |
2007 |
Mental Depression
|
0.310 |
Biomarker
|
disease |
PSYGENET |
Essential functions of synapsins I and II in synaptic vesicle regulation.
|
7777057 |
1995 |
Depressive disorder
|
0.310 |
Biomarker
|
disease |
PSYGENET |
Essential functions of synapsins I and II in synaptic vesicle regulation.
|
7777057 |
1995 |
Autism Spectrum Disorders
|
0.250 |
Biomarker
|
disease |
BEFREE |
Mutations in Synapsin (SYN) genes, particularly SYN1 and SYN2, have been recently associated with ASD and epilepsy in humans.
|
28922833 |
2017 |
Autism Spectrum Disorders
|
0.250 |
GeneticVariation
|
disease |
BEFREE |
Detailed neuropsychological assessments revealed that SYN1 Q555X male mutation carriers showed specific language impairment and mild autistic spectrum disorder.
|
26096837 |
2015 |
Autism Spectrum Disorders
|
0.250 |
GeneticVariation
|
disease |
BEFREE |
Synapsin knock-out (Syn1(-/-) ) mice display an epileptic phenotype and mutations in the SYN1 gene have been identified in individuals affected by epilepsy and/or autism spectrum disorder.
|
23818987 |
2013 |
Autism Spectrum Disorders
|
0.250 |
Biomarker
|
disease |
BEFREE |
Taken together, these findings suggest PRICKLE1 mutations contribute to ASD by disrupting the interaction with SYN1 and regulation of synaptic vesicles.
|
24312498 |
2013 |
Autism Spectrum Disorders
|
0.250 |
Biomarker
|
disease |
BEFREE |
These results demonstrate that SYN1 is a novel predisposing gene to ASDs, in addition to epilepsy, and strengthen the hypothesis that a disturbance of synaptic homeostasis underlies the pathogenesis of both diseases.
|
21441247 |
2011 |